The slip
PARKINSON RECEIPTno. 10014
25 Oct 2026, 18:53 UTColigodendrocytes, braak
predictionLRP4 in oligodendrocytes tracks Braak Lewy-body stage
registered6fdaa04e6ed16c01
discovery-0.16 p=0.680 n=9
replication-0.22 p=0.569 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.16, p 0.680)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT3de98c1cec2da46eef438bc0…
follows cb99b990d79a…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 10014: LRP4 in oligodendrocytes, braak
- power
- full sample -0.26 (p 0.302, n 18), 95% CI -0.65 to +0.24. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.15 (p 0.544, n 18). does not hold up.
- composition
- oligodendrocytes share of nuclei vs axis +0.03 (p 0.915); controlling for it: -0.10 (p 0.690, n 18). could be the mix.
- skeptic
- leave-one-out range -0.45 to -0.19, sign flips 0; without severely affected donors -0.26 (p 0.302, n 18). fragile.
- cell type
- strongest in astrocytes: +0.60 (p 0.0089, n 18) vs -0.26 in oligodendrocytes. proposing astrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for LRP4 in oligodendrocytes.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up LRP4 · astrocytes · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) +0.02 p 0.929 (needs p < 2.2e-4)